Aarti Drugs Ltd.
Share Price Target & Analysis
NSE:AARTIDRUGS
VWAP
Open
Close
High
Low
52 Week High
4.60 (1.22%)
AARTIDRUGS
(PHARMA)Turnaround Potential
52 Week Low
EPS
PE
PB
Standard
Quality
Silver
Valuation
#Analysis
NSE: AARTIDRUGS Share Price Financial Analysis & Valuation
Aarti Drugs Ltd. (AARTIDRUGS) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Small Cap company with Market Capitalization of Rs 4641.6 (in Cr). Total number of free float shares are 2.4 (in Lacs).
Aarti Drugs Ltd. is listed on NSE with Exchange ID - INE767A01016 and trading code is NSE:AARTIDRUGS with short name Aarti Drugs.
In the past 1 year, Aarti Drugs Ltd. has declared an equity dividend of Rs 1 per share. At the current share price of AARTIDRUGS at Rs 381.75, this results in a dividend yield of 0.26 %.
As per the Fundamental Analysis of NSE:AARTIDRUGS, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine AARTIDRUGS underlying value and future prospects. All of this data is available in AARTIDRUGS financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:AARTIDRUGS, it is clearly understood that AARTIDRUGS is Standard performer in terms of earnings and profit margins with an EPS of 20.35. NSE:AARTIDRUGS book value per share as of today is 147.01. The current price to book ratio for AARTIDRUGS as of Mar 06, 2026 is 2.6.
Valuation of the Stock: The current valuation of AARTIDRUGS stock is like Silver which means currently the stock is at Premium. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of AARTIDRUGS whether to BUY this stock at current valuation. The delivery percentage of AARTIDRUGS is 52.9% is very crucial parameter which shows that 52.9% investors are anticipating that the price of AARTIDRUGS share should go up with VWAP at 381.84.
Now, the main question is whether to BUY or SELL, NSE:AARTIDRUGS at current valuation.
As per latest Analysis No. #1527:-
⇑ STRONG BUY AARTIDRUGS if All Greens
⇗ BUY AARTIDRUGS (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD AARTIDRUGS (With Stop Loss) if only 1 Green
⇘ SELL AARTIDRUGS if NO Green Indicator
NSE: AARTIDRUGS Share Price Today (Mar 06, 2026)
(Aarti Drugs Ltd. Daily Analysis on the basis of AARTIDRUGS Intraday Graph & Trend)
Aarti Drugs Ltd. share price moved Up by 1.22% from its previous close of Rs 377.15. AARTIDRUGS stock last traded price is 381.75. AARTIDRUGS share price trend is Up with a total of 31699 stocks traded till now. It has touched an intraday high of Rs 384.4 and an intraday low of Rs 376.3. The AARTIDRUGS trading at 381.75, Up by Rs. 4.60, or 1.22 percent which suggests that most of the Traders are anticipating that the price of AARTIDRUGS share should go Up.
NSE: AARTIDRUGS Share Price Tomorrow Prediction
(Aarti Drugs Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of AARTIDRUGS)
Aarti Drugs Ltd. share price moved Up by 1.22%. AARTIDRUGS share price short term trend is Up. It suggests that AARTIDRUGS Share Price for Tomorrow remains the same with VWAP at 381.84 will be treated as stop loss for intraday traders. Aarti Drugs Ltd. Long term investors can follow the AARTIDRUGS long term trend as mentiond in future forecast table.
NSE Code |
NSE: AARTIDRUGS |
AARTIDRUGS Share Price Today |
381.75 |
AARTIDRUGS Share Price Target Prediction for 2026 ^ |
327.1 - 465.2 |
AARTIDRUGS Share Price Target Prediction for 2027*^ |
465.2 - 603.9 |
AARTIDRUGS Share Price Target Prediction for 2028*^ |
603.9 - 646.2 |
AARTIDRUGS Share Price Target Prediction for 2029*^ |
679 |
AARTIDRUGS Share Price Target Prediction for 2030*^ |
698 |
AARTIDRUGS Share Price Target Prediction for 2035*^ |
761 |
| AARTIDRUGS Current Book Value 2025 |
146.3 |
*Aarti Drugs Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^AARTIDRUGS share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
AARTIDRUGS Technical Analysis
Candlestick Pattern: @473.6| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 478.87 | SELL | 476.76 | SELL |
| MA_12 | 471.35 | BUY | 472.18 | BUY |
| MA_20 | 461.93 | BUY | 468.06 | BUY |
| MA_32 | 463.95 | BUY | 459.37 | BUY |
| MA_50 | 456.71 | BUY | 449.43 | BUY |
| MA_100 | 409.59 | BUY | 435.79 | BUY |
| MA_200 | 433.17 | BUY | 440.34 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 461.93 | Uptrend |
| MACD | 0.6 | BUY |
| ADX | 30.62 | Strong Trend |
| DMI (+/-) | 26.95 / 16.07 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 55.8 | Neutral |
| STOCHASTIC_K (Fast) | 18.32 | Oversold |
| STOCHASTIC_D (Slow) | 24.86 | Neutral |
| CCI | 37.15 | Neutral |
| PSAR | 449.84 | BUY |
| TRUE RANGE | 16.85 | BUY |
| ATR | 16.21 | BUY |
| WILLIAMS R | -38.76 | Neutral |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 0 | Oversold |
| STOCHASTIC RSI D | 6.6 | Oversold |
| MOMENTUM | 0 | SELL |
| Duration | Value |
|---|---|
| 1 Year | -13.31% |
| 3 Months | 47.2% |
| 1 Month | 0% |
| 1 Week | -2.84% |
| Action | Overall (%) |
|---|---|
| BUY | 63% |
| NEUTRAL / HOLD | 17% |
| SELL | 20% |
Most popular Questions & Answers about AARTIDRUGS
Aarti Drugs Ltd. stock last traded price is 381.75. AARTIDRUGS share price moved Up by 1.22% from its previous close of Rs 377.15.
Aarti Drugs Ltd. share price trend is Up with a total of 31699 stocks traded till now. It has touched an intraday high of Rs 569.6905 and an intraday low of Rs 376.3. The AARTIDRUGS trading at 381.75, Up by Rs. 4.60, or 1.22 percent which suggests that most of the Traders are anticipating that the price of AARTIDRUGS share should go Up and the Stop Loss will be around 381.84.
The market cap of Aarti Drugs Ltd. is ₹4641.6 (in Cr) as of Mar 05, 2026.
The current price to earning ratio for Aarti Drugs Ltd. as of Mar 05, 2026 is 39.13.
The current price to book ratio for Aarti Drugs Ltd. as of Mar 05, 2026 is 2.6.
The highest price of Aarti Drugs Ltd. stock is ₹564.05 in the last 52-week.
The lowest price of Aarti Drugs Ltd. stock is ₹312 in the last 52-week.
Aarti Drugs Ltd. share trading at ₹381.75, Up by Rs. 4.60, or 1.22 percent which suggests that most of the traders are anticipating that the price of AARTIDRUGS share should go Up.
In 2025, Stock price target for Aarti Drugs Ltd. (AARTIDRUGS) are ₹327.1 on downside and ₹465.2 on upside. Aarti Drugs Ltd. share price target is based on current financial year earings of the company.
In 2026, Stock price target for Aarti Drugs Ltd. (AARTIDRUGS) are ₹465.2 on downside and ₹603.9 on upside. Aarti Drugs Ltd. share price target is based on forecasted future earnings of the company.
In 2027, Stock price target for Aarti Drugs Ltd. (AARTIDRUGS) are ₹603.9 on downside and ₹646.2 on upside. Aarti Drugs Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Aarti Drugs Ltd. (AARTIDRUGS) will be around ₹698 Aarti Drugs Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of AARTIDRUGS.
The price of Aarti Drugs Ltd. (AARTIDRUGS) shares moved by 1.22%. The short-term trend for AARTIDRUGS share price is Up. It implies that the share price of AARTIDRUGS will stay the same tomorrow and that intraday traders should treat VWAP at 381.84 as a stop loss. Investors with a long-term outlook can track AARTIDRUGS long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of AARTIDRUGS stock is 244. Compared to the current market price of 381.75 INR, the AARTIDRUGS stock is Overvalued by 36.1%.
As per the fundamental analysis of Aarti Drugs Ltd. (AARTIDRUGS), it is of Standard quality in terms of earnings and profit margins with an EPS of 20.35. Aarti Drugs Ltd. book value per share as of today is 147.01. The current price to book ratio for AARTIDRUGS as of Mar 06, 2026 is 2.6.
NSE:AARTIDRUGS News & Other Useful Information about AARTIDRUGS Share Price
Peer Comparison of NSE: AARTIDRUGS
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1714.80 | 16.77 | 99.25 |
| DIVISLAB | 6196.50 | 94.7 | 578.26 |
| MEDICAMEQ | 363.95 | 6.47 | 200.56 |
| CIPLA | 1353.20 | 57.14 | 411.56 |
| DRREDDY | 1281.00 | 55.59 | 377.56 |
| PGHH | 5215.00 | 189.8 | 373.34 |
| TORNTPHARM | 4032.00 | 62.26 | 249.83 |
| BIOCON | 374.75 | 4.12 | 99.48 |
| LUPIN | 2225.70 | 126.08 | 595.77 |
| ALKEM | 5775.00 | 204.32 | 1142.87 |